STELLA PHARMA
NEWS
March 24th, 2026
Announcement regarding the Marketing Authorization Application for Borofalan (10B) used in BNCT for Angiosarcoma
We are pleased to announce that today we submitted the application to the Min……
March 17th, 2026
Announcement regarding the Marketing Authorization Application for Borofalan (10B), used in BNCT for Recurrent Meningioma
We are pleased to announce that we submitted today the application to the Minis……
February 10th, 2026
Announcement regarding the Opening of Pengbo (Hainan) BNCT Hospital
We are pleased to announce recent progress regarding the BNCT (Boron Neutron Ca……
January 26th, 2026
Publication of Phase II Randomized Controlled Trial Results of BNCT for Recurrent High-Grade Meningioma in Neuro-Oncology, a journal of the Society for Neuro-Oncology
Stella Pharma Corporation announces that the results of the Phase II randomiz……
